論文

2021年7月22日

Predictive factors for patients who need treatment for chronic post-surgical pain (CPSP) after breast cancer surgery.

Breast cancer (Tokyo, Japan)
  • Yasuaki Uemoto
  • Megumi Uchida
  • Naoto Kondo
  • Yumi Wanifuchi-Endo
  • Takashi Fujita
  • Tomoko Asano
  • Tomoka Hisada
  • Sayaka Nishikawa
  • Yusuke Katagiri
  • Mitsuo Terada
  • Akiko Kato
  • Katsuhiro Okuda
  • Hiroshi Sugiura
  • Satoshi Osaga
  • Tatsuo Akechi
  • Tatsuya Toyama
  • 全て表示

28
6
開始ページ
1346
終了ページ
1357
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1007/s12282-021-01275-4

BACKGROUND: Although chronic postsurgical pain (CPSP) after breast cancer surgery is a common and prevalent postsurgical adverse event, the need for CPSP treatment has not been investigated. This study examined the proportion of patients who needed treatment for CPSP and associated predictors. METHODS: We conducted a cross-sectional study with female patients who underwent breast cancer surgery at our institution. Participants were aged ≤ 65 years at the time of this study and were at least 1 year post surgery. The questionnaire examined the presence of and need for treatment for CPSP and included the Japanese version of the Concerns about Recurrence Scale (CARS-J). Multivariate analyses were used to identify independent predictors of needing treatment for CPSP. RESULTS: In total, 305 patients completed the questionnaire. The mean time since surgery was 67.1 months; 156 (51%) patients developed CPSP after breast cancer surgery and 61 (39%) needed treatment for CPSP. Among patients that developed CPSP, the fear of breast cancer recurrence as assessed by the CARS-J (odds ratio [OR] 2.59, 95% confidence interval [CI] 1.14-6.28, P = 0.028) and ≥ 2 postsurgical pain regions (OR 2.52, 95% CI 1.16-5.57, P = 0.020) were independent predictors of needing treatment for CPSP. CONCLUSIONS: This study is the first to identify the proportion and predictors of patients who need treatment for CPSP. Fear of breast cancer recurrence and ≥ 2 postsurgical pain regions may predict the need for CPSP treatment among patients following breast cancer surgery.

リンク情報
DOI
https://doi.org/10.1007/s12282-021-01275-4
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/34292500
ID情報
  • DOI : 10.1007/s12282-021-01275-4
  • PubMed ID : 34292500

エクスポート
BibTeX RIS